What is Mycoplasma Pneumonia?
Mycoplasma pneumonia is a type of atypical pneumonia caused by the bacterium Mycoplasma pneumoniae. Unlike typical bacterial pneumonias, it generally causes milder symptoms and is sometimes referred to as “walking pneumonia.” It is most commonly seen in school-aged children, adolescents, and young adults.
Symptoms of Mycoplasma Pneumonia
Common symptoms include:
- Persistent dry cough
- Sore throat
- Fever and chills
- Fatigue
- Headache
- Mild chest pain
- Shortness of breath
Although symptoms are usually less severe than typical pneumonia, they can linger for weeks if left untreated.
ICD-10 Code for Mycoplasma Pneumonia
The ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification) is used by healthcare providers to classify and code all diagnoses.
The ICD-10 code for Mycoplasma pneumonia is:
J15.7 – Pneumonia due to Mycoplasma pneumoniae
This code falls under the broader category:
- J15 – Bacterial pneumonia, not elsewhere classified
Use of the ICD-10 Code J15.7
The J15.7 code is typically used in:
- Medical documentation for diagnosis and treatment planning
- Health insurance claims for reimbursement
- Epidemiological tracking of infectious diseases
- Hospital and outpatient coding systems
Diagnosis and Testing
Diagnosis is usually confirmed through:
- Chest X-ray
- Blood tests (serologic testing for antibodies)
- PCR (polymerase chain reaction) test to detect Mycoplasma pneumoniae DNA
Treatment
Mycoplasma pneumonia does not respond to antibiotics like penicillin or other beta-lactam antibiotics, as the bacterium lacks a cell wall. Effective treatments include:
- Macrolides (e.g., azithromycin)
- Tetracyclines (e.g., doxycycline)
- Fluoroquinolones (in adults)
Supportive care such as rest, fluids, and fever reducers may also be recommended.
Conclusion
Understanding the ICD-10 code J15.7 for Mycoplasma pneumonia is essential for accurate clinical documentation and treatment tracking. Early diagnosis and appropriate antibiotic therapy can help manage symptoms and reduce complications, especially in vulnerable populations.